4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-22-000009
Chief Executive Officer gave up 20,045 shares (to pay taxes)
- Chief Executive Officer acquired 68,767 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kim Jong Joseph · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-26 | Exercise or conversion : show line 1 in the form | +68,767 | 1,297,425 | D | ||
| 2022-02-26 | Shares withheld for taxes : show line 2 in the form | −20,045 | $3.22 | $64,545 | 1,277,380 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-26 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −68,767 | 137,533 | D |
| 2022-02-26 | Grant or award : show line 4 in the form Common Stock Option | +627,700 | 627,700 | D |
| 2022-02-26 | Grant or award : show line 5 in the form Restricted Stock Unit | +468,500 | 468,500 | D |
Loading xslF345X03/wf-form4_164617791888639.xml…